179 related articles for article (PubMed ID: 27170414)
1. Comparative study of serum zinc concentrations in benign and malignant prostate disease: A Systematic Review and Meta-Analysis.
Zhao J; Wu Q; Hu X; Dong X; Wang L; Liu Q; Long Z; Li L
Sci Rep; 2016 May; 6():25778. PubMed ID: 27170414
[TBL] [Abstract][Full Text] [Related]
2. The effect of chronic prostatitis on zinc concentration of prostatic fluid and seminal plasma: a systematic review and meta-analysis.
Cui D; Han G; Shang Y; Mu L; Long Q; Du Y
Curr Med Res Opin; 2015; 31(9):1763-9. PubMed ID: 26173049
[TBL] [Abstract][Full Text] [Related]
3. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate.
Ogunlewe JO; Osegbe DN
Cancer; 1989 Apr; 63(7):1388-92. PubMed ID: 2465818
[TBL] [Abstract][Full Text] [Related]
4. Serum zinc level and prostatic lesion.
Rahman MT; Mumu MA; Kabir Y; Choudhury MM; Saiedullah M
Mymensingh Med J; 2012 Oct; 21(4):679-83. PubMed ID: 23134917
[TBL] [Abstract][Full Text] [Related]
5. Zinc, vitamin A and prostatic cancer.
Whelan P; Walker BE; Kelleher J
Br J Urol; 1983 Oct; 55(5):525-8. PubMed ID: 6194843
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of zinc levels in benign and malignant lesions of the prostate.
Goel T; Sankhwar SN
Scand J Urol Nephrol; 2006; 40(2):108-12. PubMed ID: 16608807
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
[TBL] [Abstract][Full Text] [Related]
8. Zinc plasma levels in prostatic carcinoma and BPH.
Lekili M; Ergen A; Celebi I
Int Urol Nephrol; 1991; 23(2):151-4. PubMed ID: 1713903
[TBL] [Abstract][Full Text] [Related]
9. Zinc levels in seminal plasma and their correlation with male infertility: A systematic review and meta-analysis.
Zhao J; Dong X; Hu X; Long Z; Wang L; Liu Q; Sun B; Wang Q; Wu Q; Li L
Sci Rep; 2016 Mar; 6():22386. PubMed ID: 26932683
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
Ho PJ; Baxter RC
Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.
Catalona WJ; Smith DS; Wolfert RL; Wang TJ; Rittenhouse HG; Ratliff TL; Nadler RB
JAMA; 1995 Oct; 274(15):1214-20. PubMed ID: 7563511
[TBL] [Abstract][Full Text] [Related]
12. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
[TBL] [Abstract][Full Text] [Related]
13. Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: possible role in cancer progression.
Housa D; Vernerova Z; Heracek J; Cechak P; Rosova B; Kuncova J; Haluzik M
Neoplasma; 2008; 55(5):442-6. PubMed ID: 18665756
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin-11 in patients with benign prostatic hyperplasia and prostate cancer.
Furuya Y; Nishio R; Junicho A; Nagakawa O; Fuse H
Int Urol Nephrol; 2005; 37(1):69-71. PubMed ID: 16132763
[TBL] [Abstract][Full Text] [Related]
15. Plasma zinc legels in prostatic disease.
Willden EG; Robinson MR
Br J Urol; 1975 Jun; 47(3):295-9. PubMed ID: 49204
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia.
Aydin A; Arsova-Sarafinovska Z; Sayal A; Eken A; Erdem O; Erten K; Ozgök Y; Dimovski A
Clin Biochem; 2006 Feb; 39(2):176-9. PubMed ID: 16413012
[TBL] [Abstract][Full Text] [Related]
17. Zinc and magnesium serum levels in patients with benign prostatic hyperplasia (BPH) before and after prazosin therapy.
Dutkiewicz S
Mater Med Pol; 1995; 27(1):15-7. PubMed ID: 8569270
[TBL] [Abstract][Full Text] [Related]
18. Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review.
Ilic D; Misso M
Maturitas; 2012 Aug; 72(4):269-76. PubMed ID: 22633187
[TBL] [Abstract][Full Text] [Related]
19. The zinc and copper content of blood leucocytes and plasma from patients with benign and malignant prostates.
Habib FK; Dembinski TC; Stitch SR
Clin Chim Acta; 1980 Jul; 104(3):329-35. PubMed ID: 6156038
[TBL] [Abstract][Full Text] [Related]
20. Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer.
Hillenbrand M; Bastian M; Steiner M; Zingler C; Müller M; Wolff JM; Seiter H; Schuff-Werner P
Anticancer Res; 2000; 20(6D):4995-6. PubMed ID: 11326656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
